FGD5 and central nervous system cancer: The results demonstrated that the high expression of SNHG16 in primary glioma patients had a lower OS (p < 0.05, Figure 10K), and in the other two lncRNA (FGD5-AS1, MIR17HG) groups, there was no apparent defined association described for SNHG16 (Figures 10I,J).